Group One Trading, L.P. Aravive, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.11 - $0.22 $9,880 - $19,761	-89,825 Reduced 38.46%	143,706 $17,000
Q3 2023 Nov 09, 2023	BUY	$0.11 - $1.76 $25,688 - $411,014	233,531 New	233,531 $30,000
Q1 2020 May 13, 2020	SELL	$3.5 - $13.77 $37,838 - $148,867	-10,811 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$6.21 - $14.02 $67,136 - $151,570	10,811 New	10,811 $148,000
Q1 2019 May 13, 2019	SELL	$3.35 - $8.27 $15,373 - $37,951	-4,589 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$3.23 - $8.7 $14,822 - $39,924	4,589 New	4,589 $16,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.